Literature DB >> 33880085

Variables Associated with Self-reported Language Impairment in Multiple Sclerosis: A Regression Analysis.

Sarah El-Wahsh, Rob Heard, Hans Bogaardt, Fiona Kumfor, Kirrie J Ballard.   

Abstract

BACKGROUND: Persons with multiple sclerosis (MS) can experience language-related symptoms such as difficulty with word finding, understanding verbal information, and structuring discourse. These symptoms have negative psychological and interpersonal consequences. Studies exploring characteristics of language impairment in MS are limited. The aim of this study was to investigate what symptom-related (eg, fatigue), demographic (eg, age), clinical (eg, MS type), social network, and quality of life (QOL) variables are associated with language impairment in MS.
METHODS: Participants were recruited internationally to complete an online questionnaire. A forward stepwise regression analysis was run with the dependent variable being a language impairment index from the Communication and Language Assessment questionnaire for persons with Multiple Sclerosis (CLAMS). Nineteen independent variables were entered into the regression.
RESULTS: Two hundred and two participants completed the questionnaire. The CLAMS language impairment score was significantly associated with self-reported cognitive impairment, speech and voice impairment, yes/no response to a binary question on presence of language impairment, group membership and participation, and QOL. The adjusted R2 value was 0.717 (P < .001).
CONCLUSIONS: Self-reported language impairment in MS is significantly associated with several symptom-related, social network, and QOL variables. These results provide an early model of language impairment in MS to guide future studies of treatment approaches and causative relationships between variables.
© 2021 Consortium of Multiple Sclerosis Centers.

Entities:  

Keywords:  Communication; Language; Multiple sclerosis (MS); Patient-reported outcome measures (PROMs); Quality of life (QOL); Regression

Year:  2021        PMID: 33880085      PMCID: PMC8047682          DOI: 10.7224/1537-2073.2020-096

Source DB:  PubMed          Journal:  Int J MS Care        ISSN: 1537-2073


  23 in total

1.  The MOS short-form general health survey. Reliability and validity in a patient population.

Authors:  A L Stewart; R D Hays; J E Ware
Journal:  Med Care       Date:  1988-07       Impact factor: 2.983

2.  Levels of Speech Usage: A Self-Report Scale for Describing How People Use Speech.

Authors:  Carolyn Baylor; Kathryn Yorkston; Tanya Eadie; Robert Miller; Dagmar Amtmann
Journal:  J Med Speech Lang Pathol       Date:  2008-12

3.  Prevalence and characteristics of dysarthria in a multiple-sclerosis incidence cohort: relation to neurological data.

Authors:  L Hartelius; B Runmarker; O Andersen
Journal:  Folia Phoniatr Logop       Date:  2000 Jul-Aug       Impact factor: 0.849

4.  The Perceived Deficits Questionnaire: Perception, Deficit, or Distress?

Authors:  Lauren B Strober; Allison Binder; Olga M Nikelshpur; Nancy Chiaravalloti; John DeLuca
Journal:  Int J MS Care       Date:  2016 Jul-Aug

5.  Satisfaction with communicative participation as defined by adults with multiple sclerosis: a qualitative study.

Authors:  Kathryn M Yorkston; Carolyn R Baylor; Estelle R Klasner; Jean Deitz; Brian J Dudgeon; Tanya Eadie; Robert M Miller; Dagmar Amtmann
Journal:  J Commun Disord       Date:  2006-11-27       Impact factor: 2.288

6.  A health-related quality of life measure for multiple sclerosis.

Authors:  B G Vickrey; R D Hays; R Harooni; L W Myers; G W Ellison
Journal:  Qual Life Res       Date:  1995-06       Impact factor: 4.147

7.  Communicative participation restrictions in multiple sclerosis: associated variables and correlation with social functioning.

Authors:  Kathryn M Yorkston; Carolyn Baylor; Dagmar Amtmann
Journal:  J Commun Disord       Date:  2014-05-26       Impact factor: 2.288

8.  How do I sound to me? Perceived changes in communication in Parkinson's disease.

Authors:  Nick Miller; Emma Noble; Diana Jones; Liesl Allcock; David J Burn
Journal:  Clin Rehabil       Date:  2008-01       Impact factor: 3.477

9.  The SF-36 in multiple sclerosis: why basic assumptions must be tested.

Authors:  J Hobart; J Freeman; D Lamping; R Fitzpatrick; A Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-09       Impact factor: 10.154

10.  Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance.

Authors: 
Journal:  Health Qual Life Outcomes       Date:  2006-10-11       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.